441 related articles for article (PubMed ID: 30600349)
1. High-sensitivity cardiac troponin decrease after percutaneous coronary intervention in patients with stable coronary artery disease.
Hamaya R; Horie T; Yonetsu T; Sugano A; Kanaji Y; Usui E; Hoshino M; Yamaguchi M; Ohya H; Sumino Y; Hada M; Hirano H; Kanno Y; Yuki H; Hirao K; Kakuta T
Heart Vessels; 2019 Jun; 34(6):948-956. PubMed ID: 30600349
[TBL] [Abstract][Full Text] [Related]
2. Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease.
Hamaya R; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Kanno Y; Murai T; Lee T; Kakuta T
Heart Vessels; 2019 Mar; 34(3):410-418. PubMed ID: 30229410
[TBL] [Abstract][Full Text] [Related]
3. Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventions.
Lupi A; Rognoni A; Lazzero M; Rolla R; Pergolini P; Bellomo G; Rossi L; Sante Bongo A; Jaffe AS
EuroIntervention; 2016 Mar; 11(12):1380-8. PubMed ID: 25405803
[TBL] [Abstract][Full Text] [Related]
4. Relation of High-sensitivity Cardiac Troponin I Elevation With Exercise to Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease.
Lima BB; Hammadah M; Kim JH; Uphoff I; Shah A; Levantsevych O; Almuwaqqat Z; Moazzami K; Sullivan S; Ward L; Sun Y; Kutner M; Ko YA; Sheps DS; Beshiri A; Murtagh G; Bremner JD; Vaccarino V; Quyyumi AA
Am J Cardiol; 2020 Dec; 136():1-8. PubMed ID: 32941818
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of statin intolerance in stable coronary artery disease patients with different levels of high-sensitive troponin.
Hai JJ; Wong YK; Wong CK; Un KC; Chan PH; Siu CW; Yiu KH; Lau CP; Tse HF
BMC Cardiovasc Disord; 2019 Jul; 19(1):168. PubMed ID: 31307391
[TBL] [Abstract][Full Text] [Related]
6. Association of major adverse cardiovascular events and cardiac troponin-I levels following percutaneous coronary intervention: a three-year follow-up study at a single center.
Huang ZS; Zheng ZD; Zhang JW; Tang LL; Zhou LL; Li SH; Xie XJ; Dong RM; Zhu JM; Liu JL
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3981-3992. PubMed ID: 32329875
[TBL] [Abstract][Full Text] [Related]
7. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
[TBL] [Abstract][Full Text] [Related]
8. Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis.
Hong YJ; Mintz GS; Kim SW; Lee SY; Okabe T; Pichard AD; Satler LF; Waksman R; Kent KM; Suddath WO; Weissman NJ
JACC Cardiovasc Imaging; 2009 Apr; 2(4):458-68. PubMed ID: 19580729
[TBL] [Abstract][Full Text] [Related]
9. High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis.
Karpouzas GA; Estis J; Rezaeian P; Todd J; Budoff MJ
Rheumatology (Oxford); 2018 Jun; 57(6):1080-1088. PubMed ID: 29554376
[TBL] [Abstract][Full Text] [Related]
10. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
Napan S; Kashinath RC; Kadri S; Orig MN; Khadra S
Coron Artery Dis; 2010 Aug; 21(5):261-5. PubMed ID: 20555264
[TBL] [Abstract][Full Text] [Related]
12. Effect of one-cycle remote ischemic preconditioning to reduce myocardial injury during percutaneous coronary intervention.
Zografos TA; Katritsis GD; Tsiafoutis I; Bourboulis N; Katsivas A; Katritsis DG
Am J Cardiol; 2014 Jun; 113(12):2013-7. PubMed ID: 24793669
[TBL] [Abstract][Full Text] [Related]
13. Selective coronary angiography, percutaneous coronary intervention and asymptomatic peri-procedural myocardial injury.
Griva M; Stastny J; Kopriva P; Slabak M; Coufal Z; Jarkovsky J; Svoboda M; Salek T; Sukupova L; Taborsky M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Dec; 163(4):324-330. PubMed ID: 30398220
[TBL] [Abstract][Full Text] [Related]
14. Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention-induced myocardial injury.
Kazmi DH; Kapoor A; Sinha A; Ambesh P; Kashyap S; Khanna R; Kumar S; Garg N; Tewari S; Goel PK
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S365-S371. PubMed ID: 30595291
[TBL] [Abstract][Full Text] [Related]
15. Cardiac troponin I for risk stratification following percutaneous coronary artery intervention in acute coronary syndromes.
Nageh T; Sherwood RA; Harris BM; Thomas MR
Catheter Cardiovasc Interv; 2002 Jan; 55(1):37-42. PubMed ID: 11793493
[TBL] [Abstract][Full Text] [Related]
16. Incremental Prognostic Value of Post-Intervention Pd/Pa in Patients Undergoing Ischemia-Driven Percutaneous Coronary Intervention.
Hakeem A; Ghosh B; Shah K; Agarwal S; Kasula S; Hacioglu Y; Bhatti S; Ahmed Z; Uretsky B
JACC Cardiovasc Interv; 2019 Oct; 12(20):2002-2014. PubMed ID: 31648762
[TBL] [Abstract][Full Text] [Related]
17. Using High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients: A Cohort Study.
Walter J; du Fay de Lavallaz J; Koechlin L; Zimmermann T; Boeddinghaus J; Honegger U; Strebel I; Twerenbold R; Amrein M; Nestelberger T; Wussler D; Puelacher C; Badertscher P; Zellweger M; Fahrni G; Jeger R; Kaiser C; Reichlin T; Mueller C
Ann Intern Med; 2020 Feb; 172(3):175-185. PubMed ID: 31905377
[TBL] [Abstract][Full Text] [Related]
18. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention.
Nageh T; Sherwood RA; Harris BM; Byrne JA; Thomas MR
Int J Cardiol; 2003 Dec; 92(2-3):285-93. PubMed ID: 14659867
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease.
Madsen DM; Diederichsen ACP; Hosbond SE; Gerke O; Mickley H
Atherosclerosis; 2017 Mar; 258():131-137. PubMed ID: 28031149
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention.
Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H
J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
